Jasminka Dragovic

832 total citations
7 papers, 338 citations indexed

About

Jasminka Dragovic is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jasminka Dragovic has authored 7 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jasminka Dragovic's work include Neuropeptides and Animal Physiology (3 papers), Hormonal Regulation and Hypertension (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Jasminka Dragovic is often cited by papers focused on Neuropeptides and Animal Physiology (3 papers), Hormonal Regulation and Hypertension (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Jasminka Dragovic collaborates with scholars based in United States. Jasminka Dragovic's co-authors include Ansuman Bagchi, Patrick R. Griffin, Judith E. Fenyk-Melody, Nancy A. Thornberry, Keith T. Schmidt, Lan Zhu, Dan Xie, Constantin Tamvakopoulos, Ranabir Sinha Roy and Xiaolan Shen and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Pharmacology and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Jasminka Dragovic

7 papers receiving 330 citations

Peers

Countries citing papers authored by Jasminka Dragovic

Since Specialization

Citations

This map shows the geographic impact of Jasminka Dragovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasminka Dragovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasminka Dragovic more than expected).

Fields of papers citing papers by Jasminka Dragovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasminka Dragovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasminka Dragovic. The network helps show where Jasminka Dragovic may publish in the future.

Co-authorship network of co-authors of Jasminka Dragovic

This figure shows the co-authorship network connecting the top 25 collaborators of Jasminka Dragovic. A scholar is included among the top collaborators of Jasminka Dragovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasminka Dragovic. Jasminka Dragovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome 2011 ·Bioorganic & Medicinal Chemistry Letters ·Milana Maletic, (unknown), Michael J. Szymonifka, Steven S. Mundt, Hratch J. Zokian, Kashmira Shah, Jasminka Dragovic, Kathy Lyons, Rolf Thieringer, (unknown), James M. Balkovec, Sherman T. Waddell	12
2	Characterization of Multidrug Resistance 1a/P-Glycoprotein Knockout Rats Generated by Zinc Finger Nucleases 2011 ·Molecular Pharmacology ·Xiaoyan Chu, Zuo‐Feng Zhang, Jocelyn Yabut, Sarah McCue Horwitz, John M. Levorse, Xiangqing Li, Lei Zhu, (unknown), (unknown), John R. Strauss, Xiaofang Li, (unknown), Jasminka Dragovic, (unknown), Raymond Evers, Myung K. Shin	35
3	Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michael M.‐C. Lo, Harry R. Chobanian, Oksana Palyha, Yanqing Kan, Theresa M. Kelly, Xiao-Ming Guan, Marc L. Reitman, Jasminka Dragovic, Kathryn A. Lyons, Ravi P. Nargund, Linus S. Lin	10
4	Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Cheng Guo, Peter R. Guzzo, Mark Hadden, Bruce J. Sargent, Larry Yet, Yanqing Kan, Oksana Palyha, Theresa M. Kelly, Xiao-Ming Guan, Kim Rosko, Karen Gagen, Joseph M. Metzger, Jasminka Dragovic, Kathryn A. Lyons, Linus S. Lin, Ravi P. Nargund	12
5	Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Steven H. Olson, Donald W. Graham, Gool F. Patel, Anne Hermanowski‐Vosatka, Steven S. Mundt, Kashmira Shah, Marty S. Springer, Rolf Thieringer, Samuel D. Wright, Jianying Xiao, Hratch J. Zokian, Jasminka Dragovic, James M. Balkovec	38
6	Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome 2005 ·Bioorganic & Medicinal Chemistry Letters ·Xin Gu, Jasminka Dragovic, Gloria C. Koo, Sam L. Koprak, (unknown), Steven S. Mundt, Kashmira Shah, Marty S. Springer, (unknown), Rolf Thieringer, Anne Hermanowski‐Vosatka, Hratch J. Zokian, James M. Balkovec, Sherman T. Waddell	40
7	The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides 2003 ·Journal of Biological Chemistry ·Lan Zhu, Constantin Tamvakopoulos, Dan Xie, Jasminka Dragovic, Xiaolan Shen, Judith E. Fenyk-Melody, Keith T. Schmidt, Ansuman Bagchi, Patrick R. Griffin, Nancy A. Thornberry, Ranabir Sinha Roy	191

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact